Business Wire

KRAFTON Achieves Record-High Quarterly Sales in Q1 2025

29.4.2025 09:00:00 CEST | Business Wire | Press Release

Share

KRAFTON, Inc. today announced its first quarter earnings results for 2025. Based on consolidated financial statements prepared in accordance with Korean International Financial Reporting Standards (K-IFRS), the company achieved a record-high quarterly sales performance of 874.2B KRW and operating profit of 457.3B KRW. In addition to high quarter-over-quarter growth, year-over-year growth has also set records with sales up by 31.3% and operating profit upby 47.3%.

Significant Growth and Core IP Direction

KRAFTON achieved significant growth across all of its business divisions, including PC (323.5B KRW), mobile (532.4B KRW), and console/others (18.3B KRW). On PC platforms, PUBG: BATTLEGROUNDS’ diversified content and strong live-service operations contributed significantly to growth while the successful launch of a new IP, inZOI, also played a pivotal role. On mobile, premium items, strategic IP collaborations, and localized marketing efforts drove increased sales. This was especially true for BATTLEGROUNDS MOBILE INDIA (BGMI), which generated positive player response through notable collaborations, including one with Indian automobile manufacturer Mahindra, which achieved the highest localized sales-to-date for the title.

The all-time high first quarter success can be attributed to the expansion of the PUBG IP franchise, as well as KRAFTON’s ongoing strategy of securing a “Big Franchise IP.” Since its transition to a Free-to-Play (F2P) model, PUBG has demonstrated its sustainability by surpassing 1.4 million concurrent users in March. Moving forward, KRAFTON will continue to enhance the player experience through collaborations with renowned artists and brands, new maps, and different game modes. The company also plans to broaden its player base and global presence by releasing new PUBG-based titles, including the extraction shooter Project Black Budget, the console-focused battle royale Project Valor, and the top-down tactical shooter PUBG: BLINDSPOT. By adopting photorealistic graphics powered by Unreal Engine 5 and introducing user-generated content (UGC), KRAFTON aims to evolve PUBG into a comprehensive “PUBG 2.0” gaming platform.

KRAFTON’s results can also be linked back to inZOI, which launched in Early Access on March 28 and sold over one million copies in its first week, becoming the fastest-selling KRAFTON title ever. Approximately 95% of its sales came from global markets, showcasing KRAFTON’s strength in creating a globally successful original IP. By continuing to leverage the title’s advanced CPC (Co-Playable Character) AI technology, Smart Zoi, KRAFTON plans to enhance gameplay and develop inZOI into another long-term franchise IP.

Exciting New Titles and Strategic Expansion in India

KRAFTON is strategically tailoring its development and publishing approach to each of its new titles. The PC life simulation game Dinkum officially launched globally on April 23 with localization expanded to 14 languages. The company plans to strengthen the Dinkum IP franchise by expanding it to new platforms and launching a spin-off game called Dinkum Together. Additionally, the highly anticipated Subnautica 2 is scheduled for Early Access later this year and aims to actively integrate player feedback into future development.

In addition to new titles, a core strategic market for KRAFTON continues to be India, where it is focused on solidifying its market position after strong growth with BGMI. In March, the company acquired a controlling stake in Indian studio Nautilus Mobile and secured the IP for Real Cricket, India's leading cricket game with over 250 million downloads and 10 million monthly active users. Building on this momentum, KRAFTON will further strengthen its localized strategy through new content, targeted marketing, additional game publishing, and ongoing business development efforts to discover its next major IP in India.

Quarterly Financial Highlights (Unit: KRW 100M)

Current quarter
performance
(Q1 2025)

QoQ
performance
(Q4 2024)

QoQ change
(%)

YoY
performance
(Q1 2024)

YoY change (%)

Sales

8,742

6,176

41.6

6,659

31.3

OP

4,573

2,155

112.2

3,105

47.3

Table: Preliminary consolidated financial results (K-IFRS) for KRAFTON, Q1 2025.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250429210674/en/

Contacts

KRAFTON
Ilyeon Cho
ilyeoncho@krafton.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye